|
1. |
OVULATORY DISTURBANCES IN PATIENTS WITH LUTEAL INSUFFICIENCY |
|
Clinical Endocrinology,
Volume 26,
Issue 2,
1987,
Page 129-136
C. J. C. M. HAMILTON,
J. L. H. EVERS,
J. HAAN,
Preview
|
PDF (520KB)
|
|
摘要:
SUMMARYIn order to study ovulatory disturbances in patients with luteal insufficiency we evaluated 210 cycles of 170 women from infertile couples by ultrasonographic follicle measurements and hormonal determinations. Only cycles with evidence of luteinization were included into the study. Mid‐luteal progesterone (P) levels were determined in relation to the ultrasonographic ovulation time or, where the follicle failed to rupture, in relation to the LH peak. In spontaneous cycles with a mid‐luteal P level below 32 nmol/l (10 ng/ml) a luteinized unruptured follicle (LUF) was found in 71.1 % of cycles, whereas in spontaneous cycles with a mid‐luteal P level above 32 nmol/l only 7.9% cycles exhibited a failure of the follicle to rupture. The same phenomenon was encountered in cycles in which agents had been given to induce ovulation. The incidence of LUF cycles in an average infertility population could be calculated to be as high as 50% if the mid‐luteal P level is below 32 nmol/l and as low as 4% if the mid‐luteal P level is above 32 nmol/l. The geometric mean mid‐luteal P level in spontaneous LUF cycles was 32.5 nmol/l, compared to 55.2 nmol/l in spontaneous ovulatory cycles (P<0001). We conclude that in patients with luteal insufficiency a high incidence is found of a failure of the follicle to rupture. The entrapment of the oocyte in the unruptured follicle constitutes an important cause of infertility in the
ISSN:0300-0664
DOI:10.1111/j.1365-2265.1987.tb00768.x
出版商:Blackwell Publishing Ltd
年代:1987
数据来源: WILEY
|
2. |
SOMATOMEDIN‐C LEVELS IN TREATED AND UNTREATED PATIENTS WITH ACROMEGALY |
|
Clinical Endocrinology,
Volume 26,
Issue 2,
1987,
Page 137-144
F. ROELFSEMA,
M. FRÖLICH,
H. DULKEN,
Preview
|
PDF (516KB)
|
|
摘要:
SUMMARYWith the aid of a recently developed commercially available radioimmunoassay for Somatomedin‐C (Sm‐C) we measured the Sm‐C levels in 38 controls, 24 untreated acromegalics, 45 inactive acromegalics and five pituitary dwarfs. With the exception of the dwarfs, the age and sex distributions for the various groups were similar. In inactive acromegalics the basal GH level (calculated as the mean of four blood samples taken during the day) was<5 mU/1; it was depressed to, or less than, 2‐5 mU/1 during the 100 g oral glucose tolerance test. The mean Sm‐C level found for control subjects was 20‐4 ± 5.1 nmol/1 and for untreated patients 85‐6 ± 25‐7 nmol/1 (mean ± SD,P12 mU/1). These results demonstrate that the Sm‐C levels are increased without exception in active acromegaly and normal in inactive patients, so that this measurement can be used for
ISSN:0300-0664
DOI:10.1111/j.1365-2265.1987.tb00769.x
出版商:Blackwell Publishing Ltd
年代:1987
数据来源: WILEY
|
3. |
METOCLOPRAMIDE‐INDUCED HYPERPROLACTINAEMIA: EFFECTS ON CORPUS LUTEUM FUNCTION, ENDOMETRIAL STEROID RECEPTOR CONCENTRATIONS AND 17β‐HYDROXYSTEROID DEHYDROGENASE ACTIVITY |
|
Clinical Endocrinology,
Volume 26,
Issue 2,
1987,
Page 145-154
A. KAUPPILA,
H. ISOTALO,
P. KIRKINEN,
U.‐M. MÄKILÄ,
M. ORAVA,
R. VIHKO,
Preview
|
PDF (564KB)
|
|
摘要:
SUMMARYInduced hyperprolactinaemia impairs ovarian follicular development, especially during the recruitment period. The consequences of hyperprolactinaemia during the luteal phase alone on corpus luteum. function have not been characterized, nor have the actions of excessive circulating PRL on the endometrium. In this study, postovulatory 5‐d administration of metoclopramide (MC) increased serum concentrations of PRL and decreased those of pregnenolone and progesterone indicating inhibition of steroidogenesis in the corpus luteum. This effect may partly explain the relatively common failure of implantation in association with induced ovulation using regimens leading to transient hyperprolactinaemia. In contrast to this, MC‐induced hyperprolactinaemia during the mid‐follicular (4 d) or early luteal phase of the cycle did not alter the concentrations of cytosol or nuclear oestrogen and progestin receptors or the activity of 17β‐hydroxysteroid dehydrogenase in endometrial tissue. Thus, transiently elevated circulating PRL does not seem to have direct effects on female sex steroid receptors or their function in the proliferative or secretory end
ISSN:0300-0664
DOI:10.1111/j.1365-2265.1987.tb00770.x
出版商:Blackwell Publishing Ltd
年代:1987
数据来源: WILEY
|
4. |
RELATIONSHIP BETWEEN HUMAN PROSTATIC EPITHELIAL CELL PROTEIN SYNTHESIS AND TISSUE DIHYDROTESTOSTERONE LEVEL |
|
Clinical Endocrinology,
Volume 26,
Issue 2,
1987,
Page 155-161
J. GELLER,
J. LIU,
J. ALBERT,
W. FAY,
C. C. BERRY,
P. WEIS,
Preview
|
PDF (423KB)
|
|
摘要:
SUMMARYTo evaluate the role of small amounts of prostatic tissue dihydrotesterone (DHT) as a stimulus to epithelial cell protein synthesis, we studied tissue from 27 patients given various androgen‐blocking drugs for 1 week before transurethral resection of the prostate (TURP) and measured epithelial protein synthesis and DHT levels in the tissue specimens. Test drugs before TURP included megestrol acetate 160 mg per day, with and without Tamoxifen 40 mg per day, or ketoconazole 1200 mg per day. The tissue was processed immediately and epithelial cells separated by digestion of tissue with 0.5% collagenase. After separation, epithelial cells were labelled with either3H‐leucine orl‐35S‐methionine. The DHT level was measured in whole prostatic tissue. Megesterol acetate alone and with tamoxifen significantly decreased both the incorporation of3H‐leucine into protein and the tissue concentration of DHT; megestrol acetate plus ketoconazole significantly decreasedl‐35S‐methionine incorporation into protein and the DHT level. When the data correlating DHT with protein synthesis using both labelling techniques were combined, the curves were parallel and a strong correlation was noted between DHT and protein synthesis over a wide range of values (P<0–001). These results suggest that in hormone‐dependent prostatic cancer even small amounts of prostatic DHT such as may occur from adrenal androgens following castration may significantly stimulate protein synthesis of the tumour
ISSN:0300-0664
DOI:10.1111/j.1365-2265.1987.tb00771.x
出版商:Blackwell Publishing Ltd
年代:1987
数据来源: WILEY
|
5. |
EFFECTS OF NALOXONE ON THE PITUITARY‐ADRENAL AXIS IN PATIENTS WITH DEXAMETHASONE‐SUPPRESSIBLE HYPERALDOSTERONISM |
|
Clinical Endocrinology,
Volume 26,
Issue 2,
1987,
Page 163-168
F. FALLO,
M. BOSCARO,
N. SONINO,
F. MANTERO,
Preview
|
PDF (431KB)
|
|
摘要:
SUMMARYEndogenous opioids may normally modulate the function of the hypothalamopituitary‐adrenal axis. We investigated whether opioid peptides play any role on aldosterone secretion in dexamethasone‐suppressible hyperaldosteronism (DSH). Clinical and hormonal effects of i.v. administration of naloxone (10 mg as a bolus) in two siblings affected by this disease and in eight normal volunteers were studied. In normals, naloxone caused a significant increase in plasma Cortisol compared with placebo, an insignificant increase in ACTH and no change in plasma renin activity (PRA) and aldosterone level. In DSH patients there was a slight increase in plasma Cortisol, no change in PRA and a marked rise of aldosterone level. In five normals retested after dexamethasone 2 mg, baseline ACTH and Cortisol were reduced and no response to naloxone was observed compared to naloxone alone. After dexamethasone, aldosterone levels were suppressed in DSH patients and unchanged in normals, and did not respond to naloxone in any case. In conclusion, naloxone may increase the responsiveness of adrenal zona fasciculata to physiological levels of ACTH in normals, since the slight increase in ACTH seems inadequate to explainper sethe marked Cortisol elevation. The marked aldosterone rise after naloxone indicates an underlying adrenal rather than pituitary abnormality in patients with DSH, and possibly implicates endogenous opio
ISSN:0300-0664
DOI:10.1111/j.1365-2265.1987.tb00772.x
出版商:Blackwell Publishing Ltd
年代:1987
数据来源: WILEY
|
6. |
NORMAL GROWTH AND PUBERTAL DEVELOPMENT DURING BROMOCRIPTINE TREATMENT FOR A PROLACTIN‐SECRETING PITUITARY MACROADENOMA |
|
Clinical Endocrinology,
Volume 26,
Issue 2,
1987,
Page 169-172
G. W. DALZELL,
A. B. ATKINSON,
D. J. CARSON,
B. SHERIDAN,
Preview
|
PDF (274KB)
|
|
摘要:
SUMMARYAn 11 ‐year‐old male presented with a 2‐year history of headache and lethargy. Serum PRL was elevated at 14 000 mU/1 and computerized tomography showed a pituitary macroadenoma. Visual fields and fundi were normal and the testes showed early pubertal changes. There was normal responsiveness of serum Cortisol but absence of GH response to hypoglycaemia. After bromocriptine therapy for 4 months serum PRL had fallen to 90 mU/1 and the tumour was not visible on repeat computerized tomography. After 7 months treatment, repeat pituitary function testing showed restoration of GH response to hypoglycaemia. Treatment with bromocriptine was continued and there was spontaneous progression of normal puberty; the serum testosterone continued to rise, and height maintained the 50th centile. Bromocriptine therapy should be considered as initial therapy in the management of prolactinomas in prepubertal pat
ISSN:0300-0664
DOI:10.1111/j.1365-2265.1987.tb00773.x
出版商:Blackwell Publishing Ltd
年代:1987
数据来源: WILEY
|
7. |
POSTURAL SUPPRESSION OF PLASMA ATRIAL NATRIURETIC POLYPEPTIDE CONCENTRATIONS IN MAN |
|
Clinical Endocrinology,
Volume 26,
Issue 2,
1987,
Page 173-178
H. SAKURAI,
M. NARUSE,
K. NARUSE,
K. OBANA,
T. HIGASHIDA,
F. KURIMOTO,
H. DEMURA,
T. INAGAMI,
K. SHIZUME,
Preview
|
PDF (381KB)
|
|
摘要:
SUMMARYThe effects of sequential changes in posture, from recumbency, to sitting and then to the upright position, each for 60 min, respectively, on the levels of plasma immunoreactive atrial natriuretic polypeptide (ANP) in healthy human subjects were studied using a radioimmunoassay (RIA) method. At the end of each change in posture, plasma ANP levels were respectively 150±16‐4 pg/ml (recumbent), 103±11‐2 pg/ml (sitting), and 78‐1±7–90 pg/ml (upright). In contrast, plasma renin concentration (PRC) and plasma aldosterone concentration (PAC) determined concomitantly with ANP showed a significant increase in response to the sitting and upright postures. Plasma ANP levels determined in normal subjects who remained in the recumbent posture for the same period did not show any significant change. This suggests that ANP is involved in the maintenance of haemodynamic homeostasis under physiological conditions and emphasizes that postural factors must be taken into account and controlled in order to evaluate plasma ANP levels properly, as well as those of P
ISSN:0300-0664
DOI:10.1111/j.1365-2265.1987.tb00774.x
出版商:Blackwell Publishing Ltd
年代:1987
数据来源: WILEY
|
8. |
PLASMA OXYTOCIN, ARGININE VASOPRESSIN AND ATRIAL NATRIURETIC PEPTIDE RESPONSES TO INSULIN‐INDUCED HYPOGLYCAEMIA IN MAN |
|
Clinical Endocrinology,
Volume 26,
Issue 2,
1987,
Page 179-185
B. M. FISHER,
P. H. BAYLIS,
B. M. FRIER,
Preview
|
PDF (443KB)
|
|
摘要:
SUMMARYThe changes in blood glucose, plasma oxytocin, plasma vasopressin, plasma atrial natriuretic peptide, serum osmolality, haematocrit and blood pressure were measured in response to acute insulin‐induced hypoglycaemia in six normal male subjects. After the i.v. administration of insulin (015 U/kg), plasma concentrations of oxytocin and vasopressin increased rapidly in all subjects and were maximal 15 min after the acute hypoglycaemic reaction (R). Haematocrit increased at the time of the hypoglycaemic reaction, but there was no change in serum osmolality. Systolic blood pressure rose and diastolic blood pressure fell, but mean arterial blood pressure remained unchanged. No changes were demonstrated in plasma concentrations of atrial natriuretic peptide. The release of oxytocin and vasopressin in response to acute hypoglycaemia in man is probably caused by stimulation of the posterior pituitary gland via hypothalamic activation, and not by stimulation of osmoreceptors or baroreceptor
ISSN:0300-0664
DOI:10.1111/j.1365-2265.1987.tb00775.x
出版商:Blackwell Publishing Ltd
年代:1987
数据来源: WILEY
|
9. |
AMENORRHOEA IN CYSTIC FIBROSIS |
|
Clinical Endocrinology,
Volume 26,
Issue 2,
1987,
Page 187-195
R. J. STEAD,
M. E. HODSON,
J. C. BATTEN,
J. ADAMS,
H. S. JACOBS,
Preview
|
PDF (590KB)
|
|
摘要:
SUMMARYMenstrual history in relation to nutritional status and lung function was assessed in 45 adolescent and adult patients with cystic fibrosis (CF). Twenty patients had regular menstrual cycles (of whom six had been pregnant), 12 had primary or secondary amenorrhoea, 11 had irregular cycles and two were pre‐menarcheal. Patients with regular menstruation had a significantly higher body mass index and percentage body fat (estimated from skinfold thickness measurements) than those with amenorrhoea (P
ISSN:0300-0664
DOI:10.1111/j.1365-2265.1987.tb00776.x
出版商:Blackwell Publishing Ltd
年代:1987
数据来源: WILEY
|
10. |
BROMOCRIPTINE TREATMENT OF WOMEN WITH CLOMIPHENE‐RESISTANT POLYCYSTIC OVARY SYNDROME |
|
Clinical Endocrinology,
Volume 26,
Issue 2,
1987,
Page 197-203
D. W. POLSON,
H. D. MASON,
S. FRANKS,
Preview
|
PDF (445KB)
|
|
摘要:
SUMMARYTwenty‐three patients with polycystic ovary syndrome and anovulatory infertility have been treated with bromocriptine. All had previously failed to respond to clomiphene. Twenty had normal serum prolactin concentrations and, of these, four (20%) developed regular ovulatory cycles. All three women with moderate hyperprolactinaemia ovulated regularly on bromocriptine so that, overall, seven of 23(30%) responded, which was a significantly higher proportion than that observed during a control period of no treatment. A further eight women ovulated at least once during the study period but these occasional ovulations were no more common during bromocriptine than with either clomiphene or no treatment. No suppression of LH was noted except during the luteal phase of ovulatory cycles and there was no change in the pattern of pulsatile release of LH. Testosterone and androstenedione concentrations remained elevated and unchanged. We conclude that bromocriptine may be expected to induce ovulation in hyperprolactinaemic women with polycystic ovary syndrome but that there is no clear indication for its use in clomiphene‐resistant patients with normal serum prolactin concentrati
ISSN:0300-0664
DOI:10.1111/j.1365-2265.1987.tb00777.x
出版商:Blackwell Publishing Ltd
年代:1987
数据来源: WILEY
|
|